Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice
Xiaolei Wang,1,2 Yanbin Gao,1,2 Nianxiu Tian,1 Dawei Zou,2 Yimin Shi,1 Nan Zhang1,2 1Department of Endocrinology, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China; 2Department of Endocrinology, Beijing Key Laboratory of Traditional Chinese Medicine Collateral Disea...
Main Authors: | Wang X, Gao Y, Tian N, Zou D, Shi Y, Zhang N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/astragaloside-iv-improves-renal-function-and-fibrosis-via-inhibition-o-peer-reviewed-article-DDDT |
Similar Items
-
Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB P65 subunit
by: Wang X, et al.
Published: (2018-09-01) -
Astragaloside IV Inhibits the Up-Regulation of Wnt/β-Catenin Signaling in Rats with Unilateral Ureteral Obstruction
by: Li Wang, et al.
Published: (2014-04-01) -
Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy
by: Du N, et al.
Published: (2018-10-01) -
Down-Regulation of PERK-ATF4-CHOP Pathway by Astragaloside IV is Associated with the Inhibition of Endoplasmic Reticulum Stress-Induced Podocyte Apoptosis in Diabetic Rats
by: Yifang Chen, et al.
Published: (2014-06-01) -
Role of TGF-β/Smad Signaling Pathway-Related Proteins in Clinicopathological Features and Prognosis and Survival of Patients with Nasopharyngeal Carcinoma
by: Yanwei Rao, et al.
Published: (2021-03-01)